Incidence and risk of hand-foot skin reaction with cabozantinib, a novel multikinase inhibitor: a meta-analysis-Reference-Cited by-同舟云学术

Incidence and risk of hand-foot skin reaction with cabozantinib, a novel multikinase inhibitor: a meta-analysis

Published:2015-05-25 Issue:1 Volume:41 Page:8-15
ISSN:0307-6938
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:Clin Exp Dermatol

Author:

Belum V. R.¹,Serna-Tamayo C.¹,Wu S.²³,Lacouture M. E.¹

Affiliation:

1. Dermatology Service; Department of Medicine; Memorial Sloan Kettering Cancer Center; New York NY USA

2. Division of Medical Oncology; Department of Medicine; State University of New York at Stony Brook; Stony Brook NY USA

3. Division of Haematology and Oncology; Department of Medicine; Northport VA Medical Center; Northport NY USA

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ced.12694/fullpdf

Reference25 articles.

1. Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth;Yakes;Mol Cancer Ther,2011

2. Cabozantinib in progressive medullary thyroid cancer;Elisei;J Clin Oncol,2013

3. Activity of cabozantinib (XL184) in soft tissue and bone: Results of a phase II randomized discontinuation trial (RDT) in patients (pts) with advanced solid tumors;Gordon;ASCO Meeting Abstracts,2011

4. Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial;Smith;J Clin Oncol,2013

5. The effect of hand-foot skin reaction associated with the multikinase inhibitors sorafenib and sunitinib on health-related quality of life;Nardone;J Drugs Dermatol,2012

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in the use of tyrosine kinase inhibitors against thyroid cancer;Expert Opinion on Pharmacotherapy;2024-08-12

2. The efficacy and safety of cabozantinib in patients with metastatic or advanced renal cell carcinoma: a systematic review and meta-analysis;Baylor University Medical Center Proceedings;2024-06-17

3. Toxic Skin Reactions Should Be Differentiated from Allergic Reactions to Chemotherapeutic Drugs in Children: A Case Series and Review of the Literature;Dermatitis®;2024-06-01

4. Electrolyte disorders induced by six multikinase inhibitors therapy for renal cell carcinoma: a large-scale pharmacovigilance analysis;Scientific Reports;2024-03-07

5. Adverse Events of Cabozantinib as a Potential Prognostic Factor in Metastatic Renal Cell Carcinoma Patients: Real-World Experience in a Single-Center Retrospective Study;Biomedicines;2024-02-09